India likely to waive customs duty on COVID-19 vaccine imports

The government presently levies 10 per cent customs or import duty plus a 16.5 per cent I-GST and social welfare surcharge on vaccines coming from overseas. These taxes would make the imported vaccines costlier than the ones made by Serum Institute of India (SII) and Bharat Biotech.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3dxzHhL
via IFTTT